Skip to content

Cutting Balloon Versus Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients

Randomized Trial Comparing a Cutting Balloon to a Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01321866
Acronym
PREST
Enrollment
42
Registered
2011-03-24
Start date
2012-05-31
Completion date
2015-12-31
Last updated
2016-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriovenous Fistula, Fistula

Keywords

Angioplasty, cutting balloon

Brief summary

The main objective of this study is to evaluate and compare the primary patency rate at 12 months in a group of hemodialysis patients operated on by cutting balloon and in a group of hemodialysis patients operated by conventional balloon.

Interventions

Angioplasty of fistula stenosis using a cutting balloon

PROCEDUREAngioplasty

Angioplasty of fistula stenosis using a non-cutting balloon

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is available for 12 months of follow-up * The patient is on hemodialysis because of chronic renal insufficiency * The patient's vascular access is an arterio-venous fistula * The patient has a venous stenosis in the fistula (first event in the studied zone) * The patient is scheduled for angioplasty

Exclusion criteria

* The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection, under tutorship or curatorship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * The patient cannot fluently read French * The patient cannot understand French * The patient is pregnant * The patient is breastfeeding * Short term dialysis * The vascular access is a graft * The stenosis in question is a recurrence, and not a first event in the studied zone * The life expectancy of the patient is \< 12 months * Medical emergency situation * Peritoneal dialysis * At-home dialysis

Design outcomes

Primary

MeasureTime frameDescription
Primary patency12 monthsPrimary patency following a first angioplasty of a first stenose in the affected zone.

Secondary

MeasureTime frameDescription
Number of re-stenoses12 monthsStenosis defined as lumen diameter \< 2mm
Total days in hospital12 monthsThe total number of days hospitalized for stenosis, thrombosis, or recovering vascular access. This does not include regular hemodialysis activities.
Number of stents used12 monthsThe total number of stents placed between the study angioplasty and the end-of-study visit.
Total number of venous thromboses12 monthsTotal number of venous thromboses between study angioplasty and end-of-study visit
Direct medical costs (€)12 months
Indirect costs (€)12 months
Number of early re-stenoses3 monthsstenosis defined as lumen diameter \< 2mm
Questionnaire SF3612 months
Fistula quality (cm*ml/min)Baselinecumulative length of usable fistula (cm) \* venous flow during the last hemodialysis (ml/min)
% StenosisBaseline100-((the smallest diameter of the stenosis lumen (mm)/ the diameter of a proximal, normal portion of lumen (mm))\*100)
Presence/absence of complications associated with the angioplastyDay of intervention
Presence/absence of complications since the last visit6 months
Questionnaire KDQOL12 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026